Your revenue problem is not a marketing problem.

Spend amplifies the system you already have. If the underlying commercial process is broken — no clear ICP, no attribution, misaligned handoffs, wrong channel mix — more budget produces more activity and the same revenue.

Diagnose before you fund. Look at pipeline volume, then conversion by stage, then win rate, then retention. Wherever the number collapses is where the money is leaking. At IBM, €220M of net new pipeline across twenty European markets came from rebuilding the engine, not from increasing the budget.

Neither. It is an alignment failure. Marketing is measured on volume, sales on revenue, and nobody has agreed what a qualified opportunity actually is.

The fix is one shared ICP, one pipeline definition, and joint accountability for conversion — not more leads and not better nurture. At Foodhub, restructuring the commercial function across five international markets moved marketing ROI from −18% to +22% in twelve months.

Usually positioning, not product. The market does not understand who it is for, what it replaces, or why now.

The test: can your sales team explain the value in one sentence without a deck? If they cannot, buyers cannot either. This is a commercial problem disguised as a marketing one, and it gets solved upstream — ICP, category and the story — before any campaign runs.

That is the most common bottleneck at this stage, and it is expensive in two ways: your time, and the decisions not being made while you are stretched.

The choice is a full-time CMO hire — six-month search, full package, high risk if wrong — or embedded senior leadership within weeks. Most founders at 20 to 200 people do not need a permanent executive yet. They need someone senior owning the outcome now.

This is a narrative and instrumentation problem, and it is fixable in a quarter.

Investors at Series B want pipeline predictability, CAC payback, net revenue retention, and evidence that revenue is not founder-dependent. Building those takes two things: an attribution model that works, and a commercial story that connects marketing activity to revenue outcomes the board can verify. Start twelve to eighteen months before you raise, not three.

Revenue failures trace to one of five causes: broken marketing, broken sales, misalignment between them, weak product marketing, or a broken commercial process. The sequence tells you which.

• No pipeline — marketing
• Pipeline that does not convert — sales or alignment
• Deals that convert but churn — product marketing or fit
• Everything working but nothing repeatable — process

Diagnose in that order.

Because execution without direction produces motion, not results. A team of specialists running channels with no one owning the commercial outcome will always underperform.

The gap is usually seniority — nobody in the room has run this before at scale and nobody is accountable for revenue. Adding headcount to an unowned function multiplies the problem.

The titles describe scope, not seniority. A Chief Marketing Officer owns marketing: brand, demand and pipeline. A Chief Commercial Officer owns the full commercial function including sales, partnerships and often pricing. A Chief Growth Officer owns growth across the whole revenue system including product-led motions and retention.

The right scope depends on where your revenue is breaking. If the constraint sits between marketing and sales, a marketing-only mandate rarely fixes it.